| __timestamp | BioCryst Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 38783000000 |
| Thursday, January 1, 2015 | 13047000 | 42585000000 |
| Friday, January 1, 2016 | 11253000 | 45702000000 |
| Sunday, January 1, 2017 | 13933000 | 46372000000 |
| Monday, January 1, 2018 | 29514000 | 46910000000 |
| Tuesday, January 1, 2019 | 37121000 | 48890000000 |
| Wednesday, January 1, 2020 | 67929000 | 50129000000 |
| Friday, January 1, 2021 | 118818000 | 54559000000 |
| Saturday, January 1, 2022 | 159371000 | 62081000000 |
| Sunday, January 1, 2023 | 213894000 | 105931000000 |
| Monday, January 1, 2024 | 77201000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Dr. Reddy's Laboratories consistently outpaced BioCryst, with expenses peaking at over 105 billion in 2023, a staggering 170% increase from 2014. In contrast, BioCryst's SG&A expenses grew by approximately 2800% during the same period, reaching 214 million in 2023. This dramatic rise reflects BioCryst's aggressive expansion and investment strategies. However, the data for 2024 is incomplete, leaving room for speculation on future trends. These insights highlight the strategic financial decisions shaping the competitive landscape of the pharmaceutical sector.
Cost Management Insights: SG&A Expenses for Novartis AG and BioCryst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Genmab A/S vs BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and BioCryst Pharmaceuticals, Inc.
Veracyte, Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
BioCryst Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?